author-photo

Hanne Merete Lindegaard

Odense University Hospital

177

Papers

3360

Citations

Citation Trend

Filter By

Papers (123) Sort By

Journal Conference Others

POS0377 FIBROCYTES IN EARLY AND LONGSTANDING RHEUMATOID ARTHRITIS: A 6-MONTH TRIAL WITH REPEATED SYNOVIAL BIOPSY, IMAGING, AND LUNG FUNCTION TEST

2021 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial.

2021 Scandinavian Journal of Rheumatology
Show All
- Source
- Cite
- Save
Citations (0)
In vitro effect of biological and conventional disease-modifying antirheumatic drugs on fibrocyte differentiation in patients with rheumatoid arthritis and healthy controls.

2021 European Journal of Rheumatology
Show All
- Source
- Cite
- Save
Citations (0)
Use and utility of serologic tests for rheumatoid arthritis in primary care.

2020 Danish Medical Journal
Show All
- Source
- Cite
- Save
Citations (2)
Rheumatoid arthritis treatment associated changes in circulating bone-turnover markers

2020 Bone reports
Show All
- Source
- Cite
- Save
Citations (0)
SAT0130 TREAT-TO-TARGET STRATEGY OF >8.000 PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: DOES SMOKING AFFECT ACHIEVEMENT OF REMISSION ON METHOTREXATE AND TIME TO START OF FIRST BIOLOGIC? RESULTS FROM THE NATIONWIDE DANISH DANBIO REGISTRY

2020 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
FRI0019 MRI INFLAMMATION, DISEASE ACTIVITY AND FUNCTIONAL IMPAIRMENT ARE MORE EFFECTIVELY REDUCED BY ESCALATION TO BIOLOGICS COMPARED TO CSDMARD-ESCALATION IN RHEUMATOID ARTHRITIS PATIENTS IN CLINICAL REMISSION FOLLOWING A TREAT-TO-TARGET STRATEGY: SECONDARY ANALYSES OF THE IMAGINE-RA TRIAL

2020 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
AB0209 PREDICTORS OF ACHIEVING STRINGENT REMISSION IN PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS IN CLINICAL REMISSION FOLLOWING A TREAT-TO-TARGET STRATEGY

2020 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Complement activation in human autoimmune diseases and mouse models; employing a sandwich immunoassay specific for C3dg.

2020 Journal of Immunological Methods
Show All
- Source
- Cite
- Save
Citations (1)
Predictors of joint damage progression and stringent remission in patients with established rheumatoid arthritis in clinical remission.

2020 Rheumatology
Show All
- Source
- Cite
- Save
Citations (3)